Overexpression of dihydrodiol dehydrogenase is associated with cisplatin-based chemotherapy resistance in ovarian cancer patients
- 30 April 2005
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 97 (1), 110-117
- https://doi.org/10.1016/j.ygyno.2004.12.031
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Inverse expression of dihydrodiol dehydrogenase and glutathione‐S‐transferase in patients with esophageal squamous cell carcinomaInternational Journal of Cancer, 2004
- Increased Expression of Dihydrodiol Dehydrogenase Induces Resistance to Cisplatin in Human Ovarian Carcinoma CellsPublished by Elsevier BV ,2002
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Drug Resistance-Associated Marker Lrp for Prediction of Response to Chemotherapy and Prognoses in Advanced Ovarian CarcinomaJNCI Journal of the National Cancer Institute, 1995
- Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic FactorsJNCI Journal of the National Cancer Institute, 1994
- Clinical Correlates of MDR1 (P-glycoprotein) Gene Expression in Ovarian and Small-Cell Lung CarcinomasJNCI Journal of the National Cancer Institute, 1992
- Ovarian cancer, Part I: BiologyCurrent Problems in Cancer, 1992
- Characterization of dihydrodiol dehydrogenase in human liver and lungCarcinogenesis: Integrative Cancer Research, 1990
- Characterization of dihydrodiol dehydrdrogenase in human liver and lungCarcinogenesis: Integrative Cancer Research, 1990
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958